Let’s meet at CPHI Milan 2026

Connecting research, development, manufacturing, and supply to cut through outsourcing complexity and streamline the drug development journey.

October 6–8, 2026

In-person

Fiera Milano, Italy

Booth: 6A2

Event website

Drug development no longer happens in isolated stages

As programs become increasingly interconnected, decisions made in one part of the process often affect outcomes in another.

When biotech and pharma companies work with multiple third-party partners, challenges can arise:

Repeated handoffs between vendors, increasing complexity as knowledge and processes are transferred
Limited visibility across the development lifecycle, resulting in disconnected data and decision-making
Siloed teams and unclear ownership, creating communication gaps and reducing operational efficiency

As a result, critical activities are executed independently, creating a fragmented approach that lacks strategic alignment.

We offer a better way.

Why Thermo Fisher Scientific?

Thermo Fisher Scientific offers a coordinated suite of solutions that integrates CDMO and CRO capabilities across the drug development ecosystem, with services purpose-built to support programs across therapeutic areas and drug modalities.

As your end-to-end partner, we're always looking ahead. During formulation development, we're already considering later-stage manufacturing requirements. As clinical trials progress, we're helping lay the groundwork for global supply chain readiness.

This forward-looking approach helps reduce friction, maintain continuity, and improve decision-making from early development through commercial manufacturing and beyond—ultimately supporting your goal of getting treatments to patients faster.

About CPHI Milan 2026:

As the premier event connecting global industry experts, CPHI unites the world of pharma. From experiences that inspire innovation and drive change to in-person opportunities that foster meaningful relationships year-round, CPHI is your one-stop destination for joining a community dedicated to advancing health.

CPHI Milan 2026 will bring together top suppliers, innovators, and pharmaceutical professionals from across the biotechnology and pharmaceutical supply chain. Many of the industry's leading companies will be in attendance, including Thermo Fisher Scientific. Our team of experts looks forward to seeing you there.

Schedule a 1:1 at CPHI Milan 2026

Let's begin our journey together by meeting at CPHI Milan 2026 and discussing the specific needs of your drug development program.

Find your missing element with Thermo Fisher Scientific

Element

Trust is the foundation of a successful partnership. It allows partners to work as one team, guided by a shared vision, with the confidence that each partner reliably do what they say they will do.

Transparent and open communication is a key element to successful project management. It requires sharing relevant information, feedback, and expectations and it encourages dialogue to address concerns and issues promptly.

Element

An effective partnership is built on mutual respect, open communication, trust, collaboration, and shared objectives, instilling confidence in customers that they will be fully supported along the development journey.

Element

Enabled through tools, technologies, and industry and scientific expertise, foresight enables teams to anticipate and mitigate challenges before they arise.

Element

Navigating the complexities of drug development and manufacturing requires passion, persistence, and unwavering dedication to achieving the shared vision of transforming patients’ lives.

Element

Every project has unique requirements, objectives, and challenges. Close and continuous collaboration is vital for understanding these distinct considerations and tailoring solutions to meet them.

Element

Real-world experience borne from decades of partnering in all aspects of drug development adds critical value to every project above and beyond the advances in sciences and technology that have transformed the industry.

Element

Scientists and subject matter experts with deep understanding of the evolving pharmaceutical landscape provide the skills and perspective to set and keep projects on the path to success.

Element

Scientific, technical, and operational knowledge acquired through deep and wide industry experience is an inimitable competitive differentiator in today’s rapidly evolving industry landscape.

Element

Keeping pace with the rapidly changing pharmaceutical industry requires unprecedented operational agility and flexibility to consistently deliver high-quality, customized solutions.

Insights and resources

ホワイトペーパー

Transforming CDMO Partnerships Through Quality

CDMO品質の重要な指標を詳しく掘り下げ、継続的な改善を促進し、協力を強化し、信頼を築くためのツールとベストプラクティスをご紹介します。

ダウンロード

ブログ

Enter the CRDMO: Reshaping drug development through CRO/CDMO integration

CROとCDMOの強力な連携から生まれた「CRDMO」が、新しい時代の扉を開こうとしています。今回、CRDMOとの提携がもたらす5つの魅力的なメリットに焦点を当て、未来の医薬品開発における真の可能性を探ります。

ブログを読む

ブログ

The 5 Drug Development Phases

新薬が「成功」とみなされるためには、5つの段階を経る必要があります： 1）発見と開発、2）前臨床研究、3）臨床研究、4）FDA審査、5）安全性監視　

ブログを読む

Blog post

What is a CDMO?

製薬企業とCDMO（医薬品開発・製造受託機関）がどのように連携しているか、そしてCDMOパートナーを選ぶ際に最も考慮すべきポイントをご紹介します。

ブログを読む

ブログ

CROs vs CMOs, and CDMOs: What’s the difference between the three?

CRO、CMO、CDMOは、いずれもバイオテクノロジー企業や製薬企業の医薬品開発・製造をサポートするものですが、それぞれの違いは何でしょうか？

ブログを読む

オンデマンドウェビナー

Optimizing the cell therapy patient journey through integrated CRO CDMO partnership

このオンデマンド・ウェビナーでは、一貫したCRO/CDMOパートナーシップがどのように業界の課題を緩和し、開発から製造までのプロセスを加速するかに焦点を当てます

視聴する

インフォグラフィック

医薬品を世界市場に展開する準備をされていますか？パートナーとなるCDMOが、スピード感、セキュリティ、安定供給できる能力と共に、グローバルな規制対応を対応できる能力をしっかりと携えていることを事前に確認する必要があります。

ダウンロード

ブログ

Enabling a digital culture through integrated business processes

安定性と経験が鍵となる物理的な作業環境とは対照的に、デジタルビジネス環境ではイノベーションと接続性に重点が置かれます。

ブログを読む

ホワイトペーパー

癌領域の医薬品開発環境の変化：患者さんの命を救う新薬を上市するには

癌治療の医薬品における状況は、10年前とは全く違ってきています。

ダウンロード

eBook

製薬・バイオテクノロジー産業における持続可能性について

現在、我々は気候変動の転換期にあり、無駄にする時間は残されていません。私たちが互いに持続可能な道を歩んでいくためには、コラボレーションが不可欠です。

ダウンロード

Infographic

Cold chain services for clinical trial success

医薬品を作り上げる過程には、ラボから最終的な医薬品製造まで様々なステップがあります。だからこそ、スムーズな進行を実現するためには、計画と経験に裏打ちされた実践的なアプローチが欠かせません。後期開発をサポートするCDMOを活用することで各段階での課題を軽減することが可能です。詳細はこちらをご覧ください

ダウンロード

ホワイトペーパー

Advancing drug development using in silico modeling

データは知識であり、知識は力である。しかし、それは実用可能でなければなりません。こちらの予測モデリングは、堅牢な医薬品開発および製造プラットフォームの開発を支援することが可能です。

ダウンロード

Discover a different kind of CDMO at CPHI

Stay connected to new discoveries, innovations, and expert scientific opinions.

View insights and resources

ご登録いただくと、最新ニュースやイベント情報などをお届けします。

是非お気軽にご連絡ください。